Renal news roundup from AKF

Cadrenal Therapeutics' novel oral anticoagulant tecarfarin was granted fast track designation by the FDA to prevent systemic thromboembolism of cardiac ori...

The FDA has given CardioRenal Systems breakthrough device status for the RenalGuard therapy system. The device is designed for personalized active hydration to ...

The Personalized Drug Response: Implementation and Evaluation of Chronic Kidney Disease consortium, which will focus on developing biomarker-based assays to gui...

Blue Cross Blue Shield of Idaho has partnered with health technology firm Healthy.io to give its employees and Medicare Advantage members access to the latter&#...

Consuming high levels of omega-3 polyunsaturated fatty acids through fish was associated with a lower risk of chronic kidney disease and slower decline in renal...

Maintaining a high level of cardiorespiratory fitness could mitigate the risk for chronic kidney disease, according to long-term research published in the journ...

A survey of more than 1,500 physicians, nurse practitioners, physician assistants and pharmacists found that many hesitate to prescribe Paxlovid to COVID-19 pat...

Researchers found some variation in SGLT2i prescribing among Veterans with chronic kidney, diabetes and cardiac diseases, depending on race and sex and where th...

Based on research that supports a less restrictive diet for patients with chronic kidney disease, renal dietitians are recommending more whole foods, according ...